Bortezomib in Relapsed Multiple Myeloma – Results of a Non-Interventional Study by Office-Based Haematologists

Publisher： Karger

E-ISSN： 2296-5262|32|4|175-180

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.4, 2009-03, pp. : 175-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bortezomib-Containing Regimens Are Effective in Multiple Myeloma - Results of a Non-Interventional Phase IV Study

By  

Oncology Research and Treatment, Vol. 38, Iss. 4, 2015-03 ,pp. : 167-173

Karger

Access to resources Recommend Favorite

Treatment of Non-Transplant Patients with Multiple Myeloma: Routine Treatment by Office-Based Haematologists in Germany - Data from the Prospective Tumour Registry Lymphatic Neoplasms (TLN)

By  

Oncology Research and Treatment, Vol. 37, Iss. 11, 2014-10 ,pp. : 635-644

Karger

Access to resources Recommend Favorite

Bortezomib Retreatment in Relapsed Multiple Myeloma – Results from a Retrospective Multicentre Survey in Germany and Switzerland

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 247-254

Karger

Access to resources Recommend Favorite

Retreatment and prolonged therapy with subcutaneous bortezomib in patients with relapsed multiple myeloma: A randomized, controlled, phase III study

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 1, 2018-01 ,pp. : 10-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

RAS mutation status and bortezomib therapy for relapsed multiple myeloma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 905-908

John Wiley & Sons Inc

Access to resources Recommend Favorite